| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-05 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0007 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |